SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gennex Laboratories informs about outcome of board meeting

31 May 2023 Evaluate

Gennex Laboratories has informed that the Meeting of Board of Directors, the Board Approved and considered the following items: Audited Standalone & Consolidated Financial results for the quarter ended & Year Ended March 31, 2023 and Auditor's Report on audited Standalone & Consolidated Financial Statements for the Quarter and Year ended March 31, 2023, issued on dated May 30, 2023 along with the Statement on Impact of Audit Qualification (Standalone & Consolidated) are attached – Annexure I.

The above information is a part of company’s filings submitted to BSE.

Gennex Lab Share Price

10.41 0.11 (1.07%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×